1000Farmacie successfully raises $35 million in its Series A funding round, indicating strong investor confidence in the startup's growth potential in the healthcare industry.

Information on the Target

1000Farmacie is an innovative startup that has quickly established itself in the healthcare sector, focusing on providing accessible pharmaceutical services. The company offers an integrated platform that connects customers with local pharmacies, enhancing the ease of obtaining medication and healthcare products.

With the recent closure of a $25 million Series A funding round, alongside an additional $10 million in extended financing, 1000Farmacie demonstrates strong investor support and potential for future growth.

Industry Overview in the Target’s Specific Country

The healthcare industry in Italy, where 1000Farmacie operates, is characterized by a robust regulatory framework and a growing emphasis on digital transformatio

View Source

Similar Deals

zwei.7 Avelios

2025

Series A Healthcare Facilities & Services (NEC) Other
Demeter Phagos

2025

Series A Bio Therapeutic Drugs Other
China Development Industrial Bank Anbogen Therapeutics

2024

Series A Proprietary & Advanced Pharmaceuticals Other
比翼生醫 梅科科技

2024

Series A Hospitals, Clinics & Primary Care Services Other
Taiwania Capital Syncell

2024

Series A Biotechnology & Medical Research (NEC) Other
M Ventures, Debiopharm Innovation Fund Iktos

2023

Series A Proprietary & Advanced Pharmaceuticals Other

1000Farmacie

invested in

1000Farmacie

in 2023

in a Series A deal

Disclosed details

Transaction Size: $25M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert